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Background: This study aimed to test the validity of using the Hypomania Checklist-16 [HCL-16] to measure
hypomania in a British adolescent community sample. Limited research is available concerning the
characterization of hypomania among community adolescent samples, particularly in the UK, despite its
potential importance for early intervention policy development.
Method: To explore the structure and characterization of hypomania in a British adolescent nonclinical cohort,
over 1400 17 year olds (Mean=17.05 years; SD=0.88) completed the HCL-16 along with measures of diﬀerent
psychological and psychopathological dimensions.
Results: Principal components analysis revealed a 2-component solution for the HCL-16, described as active-
elated and irritable/risk-taking. Hypomanic symptoms were signiﬁcantly correlated with many psychopatho-
logical dimensions. There were distinct correlation patterns for the two HCL-16 subscales, with the irritability/
risk-taking subscale showing signiﬁcantly stronger associations with psychotic-like experiences, internalizing
and externalizing problems, and reduced life satisfaction relative to the active-elated dimension. Adolescents at
‘high-risk’ for bipolar disorder reported more psychopathology relative to the comparison group.
Limitations: Absence of the clinical diagnosis of bipolar disorder in the sample means that the classiﬁcation of
the ‘high-risk’ group cannot be conﬁrmed.
Conclusions: The structure of the HCL-16 in this UK adolescent sample mirrored that observed in adult and
clinical cohorts. The observed links between the HCL-16 and psychopathological dimensions that have been
previously associated with both hypomania and bipolar disorder lend support to the HCL-16's validity as a
hypomania instrument for adolescents. Better understanding of hypomania prior to adulthood has considerable
potential for informing early intervention approaches.
1. Introduction
The average age of onset for bipolar disorder [BD] ranges from 18
to 22 years (Merikangas et al., 2011), although up to 60% of people
with BD report their illness onset occurring in childhood or adoles-
cence (Perlis et al., 2009). There has been a rise in the clinical diagnosis
of pediatric BD (Moreno et al., 2007), with a meta-analysis reporting a
prevalence of 1.8% in community samples (Van Meter et al., 2011).
Thus the true age of onset may occur earlier than what is documented.
Subsyndromal hypomanic symptoms in youth have been linked to
similar severity and impairment experienced by those with clinically
diagnosed BD and have been associated with subsequent clinical
hypomanic or manic episodes (Axelson et al., 2015). Therefore a better
understanding of the characterization of hypomania during adoles-
cence may help improve accurate and timely diagnosis of BD.
Furthermore, there is increased interest surrounding pediatric BD,
but there is limited research in the UK with the majority of the
published work conducted in the US (Skirrow et al., 2012). This means
it is unclear whether the ﬁndings from US samples are generalizable to
the UK and other populations.
Currently, identiﬁcation of young people at ‘high-risk’ of developing
BD (particularly in community samples) involves screening for the
presence of hypomanic symptoms (Waugh et al., 2014). Another
approach is to focus on other elements of the diagnostic criteria, such
as the impact on functioning and symptom duration (Meyer et al.,
2007). Using German and Swedish community samples, researchers
http://dx.doi.org/10.1016/j.jad.2016.08.033
Received 1 April 2016; Received in revised form 17 August 2016; Accepted 21 August 2016
⁎ Corresponding author.
E-mail address: a.ronald@bbk.ac.uk (A. Ronald).
Journal of Affective Disorders 207 (2017) 228–235
0165-0327/ © 2016 Published by Elsevier B.V.
Available online 02 October 2016
crossmark
have found that those categorized as ‘high-risk’ adopting this approach
report experiencing externalizing (e.g. hyperactivity/inattention) and
internalizing (e.g. anxiety symptoms) problems (Holtmann et al.,
2009), which mirror the common comorbidities observed in BD
(Merikangas et al., 2011). Although these ﬁndings provide support
for the validity of this approach of identifying individuals at ‘high-risk’
of developing BD, such problems are fairly common in youth
(Goodman et al., 2000). Examination of whether other psychopatho-
logical and psychological dimensions known to co-occur with BD are
also observed among ‘high-risk’ individuals, such as psychotic-like
experiences (eg. paranoia) is needed. Also it would be of value if a more
comprehensive method of identifying young people at risk of develop-
ing BD was developed which combines existing screening methods and
which reﬂects all the key elements of diagnosis (i.e. the presence of
symptoms, their impact and duration), especially given the challenges
of diagnosing pediatric BD (Youngstrom et al., 2009). This study will
explore the validity of this more comprehensive method of identifying
adolescents that show vulnerability to BD, which could have implica-
tions for clinical practice.
Mania and hypomania can be divided into two sides or dimensions:
the ‘bright’ and ‘dark’ (Hantouche et al., 2003). The ‘bright’ side is
concerned with the socially advantageous aspects of hypomania (eg.
elation), and is also referred to as active-elated (Brand et al., 2011) or
exuberant (Stringaris et al., 2011). The ‘dark’ side is related to the
socially negative facets of hypomania (eg. irritability) and is also
referred to as irritability/risk-taking (Brand et al., 2011) or under-
controlled (Stringaris et al., 2011). Research shows that these two sides
of hypomania are diﬀerentially related to psychological impairment
and comorbid symptomatology. For example, the ‘dark’ side of
hypomania has been more strongly related to symptoms of depression,
sleep problems and less life satisfaction compared to the ‘bright’ side
(Brand et al., 2011), whereas the ‘bright’ side is associated with higher
verbal IQ (Stringaris et al., 2014).
The overall aim of this study was to test the validity of using the
Hypomania Checklist-16 [HCL-16] (Forty et al., 2010) to measure
hypomania in a British adolescent community sample. This aim was
achieved through the investigation of four speciﬁc objectives. First, the
component structure of hypomania in a nonclinical sample of British
adolescents was explored. The second objective was to assess the
construct validity of the HCL-16 through the assessment of the extent
to which the HCL-16 scores were associated with other dimensions of
psychopathology that are known to be related to clinical levels of
hypomania and BD. These included psychotic-like experiences as well
as internalizing (e.g. depression) and externalizing (e.g. hyperactivity/
inattention) problems. In addition, the relationships between hypoma-
nia, personality, life satisfaction and sleep problems were investigated.
Exploration of these relationships was undertaken since there is
evidence of links between sleep disturbance and reduced life satisfac-
tion with clinical levels of hypomania (Harvey, 2008; Michalak et al.,
2005). Previous research also shows that BD is associated with
extraversion, openness to experience, and neuroticism (Tackett et al.,
2008). Third, diﬀerences between the two hypomania dimensions
(‘bright’: active-elated and ‘dark’: irritable/risk-taking) were examined
in terms of their psychological and psychopathological correlates. The
ﬁnal objective was to explore whether dimensions of the hypomania
measure could identify, using cross-sectional data, a group of adoles-
cents that show signs of vulnerability to BD.
2. Method
2.1. Participants
This study consisted of 1440 adolescent individuals, 58% (N=830)
females, with a mean age of 17.05 years (SD=0.88; range: 15–19 years)
who took part in the second phase of the Longitudinal Experiences And
Perceptions [LEAP] project (Ronald et al., 2014). Some of the data
analysed in this study was originally collected at the ﬁrst phase of the
LEAP study, which occurred on average 9 months earlier. For more
details of the sample used in the present study see Table 1. The LEAP
sample consists of twin pairs and their parents drawn from the Twins
Early Development Study (Haworth et al., 2013). For the purposes of
the current investigation only one twin from each pair was included.
LEAP received full ethical approval and informed consent was provided
by all participants, for further details on the study see (Ronald et al.,
2014).
2.2. Materials
Lifetime hypomanic symptoms were measured using the self-report
Hypomania Checklist-16 [HCL-16] (Forty et al., 2010). The HCL-16
instructs participants to recall a period at any point in their lives when
they were in a ‘high’ state or their mood was more ‘up’ than usual.
‘Highs’ were operationalized as increases in energy, activity and mood.
Participants then indicate the presence of 16 behaviours, thoughts and
emotions related to hypomania during these ‘high’ phases using
statements such as ‘I need less sleep’. A yes/no response is given for
each statement, providing a minimum score of 0 and a maximum score
of 16 for the instrument. In the current study one item was removed (‘I
feel more ﬂirtatious and/or am more sexually active’) to avoid
oﬀending participants of this longitudinal study.
The HCL-16 also includes items enquiring about the duration and
impairment of the ‘high’ periods (overall not individual symptoms).
Participants recorded the duration of the ‘high’ periods using six
options ranging from ‘1 day′ to ‘longer than a month’. The speciﬁc
impact of the ‘high’ phases on four life domains (ie. social, family,
leisure and school/work/college) was rated using four option: no
impact, negative, positive, negative and positive. Participants also
reported on other people's reactions to their ‘high’ periods using ﬁve
responses: positively, neutral, negatively, positively and negatively and
no reactions.
The HCL-16 is based on the longer HCL-32 version originally
designed to distinguish between major depression and BD in clinical
samples (Forty et al., 2010). Both versions have been shown to have
good psychometric properties in adults (Angst et al., 2005; Forty et al.,
2010) and have been used previously in adolescent cohorts (Holtmann
et al., 2009). For instance, the HCL-32 has good speciﬁcity (0.79) and
sensitivity (0.85) in distinguishing people with BD from healthy
controls or those with major depression (Vieta et al., 2007). The
HCL-16 was completed at phase 2 of the Leap Project.
2.3. Questionnaires completed at phase 2 of the Leap Study (including
HCL-16)
Depressed mood over the past 2 weeks was measured using the
Table 1
Sample characteristics and key frequencies.
Characteristic N=1440 N (%)
Female 830 (58%)
Age (mean, SD) 17.05 years
(0.88)
White ethnicity 1331 (92%)
Family history of BD 82 (6%)
Hypomania score (mean, SD) 7.12 (2.60)
HCL−16 score of 8 or more (cut-oﬀ for hypomania) 673 (47%)
Any type of negative impact or reaction to periods of high
mooda
535 (37%)
Highsa with a duration of 2 days or more 471 (33%)
Score above HCL−16 cut-oﬀ with ‘highs’a lasting at least 2
days and any type of negative impact or reaction
124 (9%)
a Periods of high mood were operationalized in the HCL-16 as phases when the
individual experienced increases in their energy, activity and mood.
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Short version of the Moods and Feelings questionnaire [SMFQ]
designed for children and adolescents (Angold et al., 1995). The 13
SMFQ items map onto the core symptoms of depression, which are
rated with a yes/no response.
Anxiety sensitivity was assessed using the Child Anxiety Sensitivity
Index (Silverman et al., 1991) which consists of 18 statements rated on
the degree to which they are true for the participants in the last six
months using a 3-point Likert scale ranging from ‘none’ to ‘a lot’.
Psychotic-like experiences were assessed using two instruments.
The ﬁrst instrument is the Speciﬁc Psychotic Experiences
Questionnaire [SPEQ] which has been previously validated in this
adolescent sample (Ronald et al., 2014) and assesses 6 types of
psychotic-like experiences (timeframe enquired about provided in
brackets): paranoia (current, no timeframe speciﬁed), hallucinations
(current, no timeframe speciﬁed), cognitive disorganization (past
month), grandiosity (past month), anhedonia (past month) and
negative symptoms (current, no timeframe speciﬁed). Five of the six
types of psychotic-like experiences are measured using self-report with
negative symptoms based on parent report. The second instrument was
the Psychotic-Like Symptoms Questionnaire [PLIKS-Q] (Zammit et al.,
2011), which was originally developed using adolescents. This 11-item
self-report instrument covers symptoms of hallucinations, delusions
and thought interference experienced in the last year. Participants were
asked to report if they had these experiences and if so, how frequent
and distressing they were.
Family history of BD among ﬁrst and second-degree relatives was
provided by parent report.
Socioeconomic status (SES) composite score was based on parental
education, occupation and family income. The score was created as an
unit-weighted sum of the contributing measures (Hanscombe et al.,
2012).
Substance use was assessed by asking participants whether they
had used 15 diﬀerent substances (eg. cannabis) in the past 12 months.
‘Yes’ responses were classiﬁed as positive for substance use.
2.4. Questionnaires completed at phase 1 of the Leap Study (9 months
prior to the HCL-16)
Emotional and behavioural problems experienced in the last 6
months were measured using the Strengths and Diﬃculties
Questionnaire [SDQ] designed for children and adolescents
(Goodman, 1997). This self-report instrument consists of 25 items
rated on a 3-point Likert scale ranging from ‘not true’ to ‘certainly true’.
The SDQ is comprised of 5 subscales: emotional problems, prosocial
behaviour, conduct problems, hyperactivity/inattention and peer pro-
blems.
Personality traits were assessed using a 30-item self-report ques-
tionnaire that maps onto the traditional 5-factor model validated and
developed using adolescent samples (Mullins-Sweatt et al., 2006).
Life satisfaction was measured using the Brief Multidimensional
Students Life Satisfaction Scale which asks respondents to rate how
satisﬁed they are currently with ﬁve life domains (eg. family), with one
item enquiring about overall life satisfaction (Seligson et al., 2003).
Each domain is rated on a 7-point Likert scale ranging from ‘very
dissatisﬁed’ to ‘very satisﬁed’. This instrument is designed to be
completed by children and adolescents (Seligson et al., 2003).
Sleep quality over the last month was assessed using the Pittsburgh
Sleep Quality Index (Buysse et al., 1989) which consists of 17 items
which cover a range of dimensions and disturbances including sleep
duration, diﬃculties falling and staying asleep. Scores ranged from 0 to
21, with higher scores indicative of poorer sleep quality. This instru-
ment has been used previously in adolescent cohorts (Lund et al.,
2010) and was completed at the ﬁrst phase of the LEAP study (Taylor
et al., 2015).
2.5. Analyses
One twin per pair was included in all analyses, randomly selected
for birth order. Principal components analyses [PCA] were conducted
to explore the structure of the HCL-16. PCA were undertaken using
Varimax rotation and component extraction was based on visual
analysis of the scree plot. Spearman's correlations were used to explore
associations between hypomania (scores from the total scale and the
subscales) and other dimensions. T-tests or χ2 tests were used to
explore group diﬀerences; bonferroni corrections were applied when
multiple tests were conducted. The signiﬁcance of the group diﬀerences
was assessed using Cohen's d, which measured the eﬀect size, where
0.2 was considered small, 0.5 medium and 0.8 indicating a large eﬀect.
Steiger's Z tests were used to test any signiﬁcant diﬀerences between
two dependent correlations (eg. correlations between psychopatholo-
gical dimensions and the two hypomania subscales) (Steiger, 1980). All
data were analysed using version 22 of SPSS.
3. Results
The mean HCL-16 score for the entire sample was 7.12 (SD=2.60);
no signiﬁcant diﬀerences in the HCL-16 score between genders
(t(1438)=0.82, p=0.41), and those from Caucasian and other ethnic
Table 2
Principal component analysis and item endorsement for the HCL-16 in a British adolescent sample (N=1440).
Item Component 1 Component 2 Item endorsementa
‘Active-elated’ ‘Irritable/ risk-taking’
Eigenvalue 2.72 1.77 −
Variance explained (%) 18.16 11.81 −
1. I need less sleep 0.39 0.11 0.41
2. I enjoy work more 0.53 −0.19 0.74
3. I want to travel more/I do travel more 0.43 0.16 0.63
4. I spend more money/ I spend too much money 0.26 0.40 0.48
5. I take more risks in my daily life (in my work or at school and/or other activities) 0.51 0.31 0.53
6. I am more physically active (e.g sports etc.) 0.54 −0.16 0.71
7. I am less shy or inhibited 0.60 −0.03 0.78
8. I wear more colourful and more extravagant clothes/makeup 0.27 0.34 0.26
9. I think faster 0.55 0.07 0.59
10. I make more jokes or puns when I am talking 0.52 0.13 0.76
11. I get into more quarrels 0.01 0.47 0.11
12. My mood is higher, more optimistic 0.63 −0.08 0.87
13. I smoke more cigarettes −0.18 0.66 0.05
14. I drink more alcohol 0.06 0.63 0.18
15. I take more drugs (e.g. sedatives, anti-anxiety pills, stimulants etc.) −0.06 0.53 0.02
a Item mean with a higher score showing a greater frequency of endorsement (range 0–1).
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backgrounds (t(1434)=1.16, p=0.25) were observed. A signiﬁcant
positive correlation was detected between SES and hypomanic symp-
toms (rs=0.15, p≤0.001). Those that reported using substances in the
last 12 months recorded signiﬁcantly more hypomanic symptoms
compared to individuals that didn’t report such use (t(1433)=5.49,
p≤0.001).
3.1. Psychometric properties of the HCL-16
Based on examination of the scree plot, 3 components were
extracted which each had Eigenvalues of 2.72, 1.77 and 1.11 respec-
tively; together the components explained 37.34% of the variance. The
third component only consisted of 3 items (items 3, 4 and 8; listed in
Table 2), with item 3 cross loading onto Component 1. Component 3
appeared quite heterogeneous given that the items appear to map onto
expansive mood, risk-taking and increased energy. Furthermore,
Component 3's Cronbach's alpha of 0.39 was poor.
To allow for comparisons with the 2-component models identiﬁed
for the HCL (Angst et al., 2005), the principal component analysis was
restricted to a 2-component solution. For Component 1 the Eigenvalue
was 2.72 and explained 18.16% of the variance (Table 2). Nine items
loaded onto this component (eg. item 1: need less sleep; item 6: more
active), which closely resembled the ‘active-elated’ subscale (or ‘bright’
side of hypomania) established previously for the HCL in other
samples. The Eigenvalue for Component 2 was 1.77 accounting for
11.81% of the variance. This component consisted of 6 items and was
similar to the ‘irritable/risk-taking’ subscale (or ‘dark’ side of hypoma-
nia) previously identiﬁed for this questionnaire (Forty et al., 2010).
Example items from this scale include spending more money (item 4)
and having more quarrels (item 11). A total of 29.97% of the variance
was explained by this 2-component model comparable with previous
studies using this instrument (Forty et al., 2010). A moderate correla-
tion between the two components from the principal component
analysis was found (r=0.43, p=≤0.001) and the correlations between
items ranged from r=0.002 and r=0.33.
The items most frequently endorsed in this sample were: higher
mood/more optimistic, and less shy or inhibited (Table 2). The
following items were endorsed the least: smoking more cigarettes
and taking more drugs (Table 2). The Cronbach's alphas for the HCL-
16 in this sample was 0.66; 0.67 for the ﬁrst subscale (‘bright’ side or
active-elated) and 0.42 for the second subscale (‘dark’ side or irritable/
risk-taking).
3.2. Family history of BD
Individuals with a family history of BD had higher mean scores on
the HCL-16 (t(1420)=1.37, p=0.17) and on the active-elated subscale
(t(1395)=1.99, p=0.047) compared to those without such family
history but only the latter was signiﬁcant. Similar mean scores on the
irritable/risk-taking scale were found among those with and without a
family history of BD (t(1394)=0.67, p=0.50).
Table 3
Correlations between hypomania, psychological and psychopathological dimensions.
Dimension HCL-16 total scorea Bright side of hypomaniaa Dark side of hypomaniaa Steiger's z-testb
(active-elated) (Irritable/ risk-taking)
Internalizing problems
Depressive symptoms 0.23*** 0.13*** 0.27*** z=5.18, p≤0.002
Anxiety sensitivity 0.25*** 0.19*** 0.25*** z =2.42, p=0.015
Psychotic-like experiences
SPEQ Paranoia 0.25*** 0.17*** 0.27*** z =3.85, p≤0.002
SPEQ Hallucinations 0.29*** 0.21*** 0.27*** z =2.07, p=0.039
SPEQ Cognitive disorganization 0.20*** 0.08*** 0.26*** z =6.35, p≤0.002
SPEQ Grandiosity 0.26*** 0.22*** 0.23*** z = 0.26, p=0.797
SPEQ Anhedonia 0.22*** 0.22*** 0.16*** z =2.14, p=0.032
SPEQ Negative symptomsc −0.01 −0.06 0.06 z =4.07, p≤ 0.002
Psychotic-Like Symptoms (PLIKS-Q) 0.23*** 0.15*** 0.22*** z =2.68, p=0.007
Exploratory analysesd
SDQ Emotional problems 0.12*** 0.05 0.16*** z =3.79, p≤0.002
SDQ Hyperactivity/inattention 0.15*** 0.05 0.19*** z =5.30, p≤0.002
SDQ Conduct problems 0.17*** 0.07 0.20*** z =4.85, p≤0.002
SDQ Peer problems 0.05 −0.01 0.12*** z =4.52, p≤0.002
SDQ Prosocial behaviour 0.06 0.09*** 0.01 z =2.77, p=0.005
Personality dimensions
Extraversion 0.18*** 0.16*** 0.13 z=0.81, p=0.417
Neuroticism 0.03 −0.02 0.09 z =2.50, p=0.012
Openness to experience 0.14*** 0.13*** 0.10 z=0.78, p=0.433
Agreeableness 0.01 0.03 0.003 z =0.53, p=0.594
Conscientiousness 0.02 0.08 −0.01 z =1.95, p=0.05
Other dimensions
Sleep problems 0.20*** 0.15*** 0.21*** z =1.91, p=0.056
Life satisfaction −0.09*** −0.01 −0.15*** z =−4.99, p≤0.002
Abbreviations: HCL-16, Hypomania Checklist 16; SPEQ, Specific Psychotic Experiences Questionnaire; PLIKS-Q, Psychotic-Like Symptoms Questionnaire; SDQ, Strengths and
Difficulties Questionnaire
*** p≤0.002 (Bonferroni corrected signiﬁcance level)
a Sample size ranged from 560 to 1438
b Signiﬁcant diﬀerences (set at p≤0.002) between correlations with each dimension and the 2 hypomania sub-scales
c Parent rated, all other scales are based on self-report
d Instruments completed at a diﬀerent time point to the HCL-16 (exploratory analysis)
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3.3. Correlations between HCL with psychological and
psychopathological dimensions
The associations between HCL-16 (total score and its two sub-
scales) and various psychological and psychopathological dimensions
are presented in Table 3. The HCL-16 total score was signiﬁcantly
correlated with all of the psychotic-like symptoms, depressed mood
and anxiety sensitivity, except for SPEQ Negative symptoms (rs=0.01,
p > 0.002). Other constructs were measured prior to the HCL-16 (SDQ
and all of the remaining psychological dimensions), therefore the
analyses considering the associations between these dimensions were
undertaken in an exploratory capacity. These analyses revealed sig-
niﬁcant correlations between the HCL-16 total score with all of the
SDQ subscales except for peer problems (rs=0.05, p > 0.002) and
prosocial behaviour (rs=0.06, p > 0.002). The HCL-16 total score was
also signiﬁcantly related to sleep problems (rs=0.20, p≤0.002) and
decreased life satisfaction (rs=−0.09, p≤0.002). Exploratory analyses
only showed signiﬁcant associations with two personality constructs:
extraversion (rs=0.18, p≤0.002) and openness to experience (rs=0.14,
p≤0.002).
There were distinct correlation patterns for the two HCL-16
subscales, with the ‘dark’ side or irritability/risk-taking subscale
showing signiﬁcantly stronger associations with all of the psychotic-
like experience dimensions and depressed mood, with only a few
exceptions. The ‘bright’ and ‘dark’ side of hypomania showed compar-
able correlations with SPEQ Grandiosity (z=0.26, p > 0.002), SPEQ
Hallucinations (z=2.07, p > 0.002) and psychotic-like symptoms mea-
sured by the PLIKS-Q (z=2.68, p > 0.002). SPEQ Anhedonia was more
strongly correlated to the ‘bright’ rather than the ‘dark’ side of
hypomania (z=2.14, p=0.032). In comparison, the exploratory analyses
showed that the ‘dark’ side had signiﬁcantly stronger correlations
relative to the ‘bright side’ for 5 of the 12 dimensions. These were:
SDQ emotional problems (z=3.79, p≤0.002), SDQ hyperactivity
(z=5.30, p≤0.002), SDQ conduct problems (z=4.85, p≤0.002), SDQ
peer problems (z=5.52, p≤0.002), and lower life satisfaction (z=−4.99,
p≤0.002).
Table 4
Mean differences between the ‘high-risk’ for hypomania and comparison groups.
Dimension ‘High-risk’ group (N=124) a Mean
(SD) or N (%)
Comparison group (N=1316)b Mean (SD)
or N (%)
Statisticc Cohen's dd
Age 16.99 (0.84) 17.05 (0.88) t(1438)=0.81, p >
0.002
0.07
White ethnic origin 115 (93%) 1216 (92%) χ2(1)=0.001, p > 0.002
Socioeconomic status composite score 0.08 (1.09) 0.02 (0.98) t(645)=0.47, p > 0.002 0.06
Family history of bipolar disorder 7 (6%) 75 (6%) χ2(1)=0.00, p > 0.002
Internalizing problems
Depressive symptoms 6.53 (6.18) 4.17 (5.52) t(148)=4.15, p≤0.002 0.40
Anxiety sensitivity 10.39 (6.18) 7.97 (6.29) t(1437)=4.09,
p≤0.002
0.39
Psychotic-like experiences
SPEQ Paranoia 20.45 (14.96) 14.30 (13.66) t(1435)=4.74,
p≤0.002
0.43
SPEQ Hallucinations 9.76 (8.30) 6.51 (7.47) t(1437)=4.58,
p≤0.002
0.41
SPEQ Cognitive disorganization 5.26 (2.75) 4.42 (3.12) t(154)=3.20, p≤0.002 0.29
SPEQ Grandiosity 6.69 (4.96) 4.57 (4.73) t(1436)=4.74,
p≤0.002
0.44
SPEQ Anhedonia 35.73 (6.74) 32.71 (8.15) t(159)=4.68, p≤0.002 0.40
SPEQ Negative symptoms e 3.66 (4.46) 3.73 (4.77) t(1423)=0.15, p >
0.002
0.02
Psychotic-Like Symptoms (PLIKS-Q) 2.27 (2.63) 1.25 (2.20) t(138)=4.17, p≤0.002 0.42
Exploratory analysesf
SDQ Emotional problems 3.78 (2.36) 3.10 (2.45) t(1434)=1.92, p >
0.002
0.28
SDQ Hyperactivity/inattention 4.19 (2.13) 3.84 (2.54) t(158)=1.75, p > 0.002 0.15
SDQ Conduct problems 2.18 (1.54) 1.80 (1.61) t(1434)=2.51, p >
0.002
0.24
SDQ Peer problems 2.16 (1.85) 1.84 (1.77) t(1434)=1.51, p.0.002 0.18
SDQ Prosocial behaviour 6.88 (2.20) 7.05 (2.07) t(1433)=0.86, p >
0.002
0.08
Personality dimensions
Extraversion 3.61 (0.71) 3.59 (0.68) t(566)=0.22, p > 0.002 0.03
Neuroticism 2.94 (0.65) 2.65 (0.71) t(567)=2.65, p > 0.002 0.43
Openness to experience 3.83 (0.57) 3.57 (0.62) t(565)=2.78, p > 0.002 0.44
Agreeableness 3.65 (0.61) 3.65 (0.65) t(564)=0.04, p > 0.002 0.00
Conscientiousness 3.68 (0.62) 3.74 (0.66) t(563)=0.60, p > 0.002 0.09
Other dimensions
Sleep problems 6.24 (2.68) 5.99 (3.02) t(1106)=0.82, p >
0.002
0.09
Life satisfaction 5.18 (1.13) 5.49 (1.23) t(1435)=2.64, p >
0.002
0.26
Abbreviations: HCL-16, Hypomania Checklist 16; SD, standard deviation; SPEQ, Specific Psychotic Experiences Questionnaire; PLIKS-Q, Psychotic-Like Symptoms Questionnaire,
SDQ, Strengths and Difficulties Questionnaire.
a HCL-16 score of 8 or more with ‘highs’lasting at least 2 days with negative consequences
b Please note that there are diﬀerences in the sample sizes due to missing data
c Signiﬁcance was set at p≤0.002 after Bonferonni correction for multiple testing was applied
d Assessing signiﬁcant diﬀerences between the groups focuses on the eﬀect size calculated using Cohen's d, where 0.2 is considered small, 0.5 medium and 0.8 large eﬀects
e Parent-rated, all other scales are based on self-report
f Dimensions measured prior to the HCL-16 thus associations undertaken in exploratory capacity.
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3.4. Proﬁle of individuals who were hypothesized to be at ‘high-risk’
for BD
Individuals at ‘high-risk’ for BD were categorized as those with a
HCL-16 score of 8 or more (instrument cut-oﬀ), whose highs lasted at
least 2 days and were associated with negative consequences. These
criteria take into account the key elements of the diagnostic criteria:
number, impact/impairment and duration of symptoms (APA, 2013).
Given the debate surrounding the possible shorter episode duration in
pediatric BD (Stringaris et al., 2010), ‘high’ phases of 2 days or more
was the focus here.
Based on the outlined criteria, 124 participants (9% of the sample)
were categorized as ‘high-risk’ and 1316 individuals formed the
comparison group. The ‘high-risk’ group reported signiﬁcantly more
symptoms of psychotic-like experiences (except for negative symp-
toms), depression and anxiety sensitivity relative to the comparison
group with small eﬀect sizes. The exploratory analyses revealed several
diﬀerences with small eﬀect sizes although the t-tests were non-
signiﬁcant. Speciﬁcally the ‘high-risk’ group's mean score on openness
to experience (t(565)=2.78, p > 0.002, d=0.44), neuroticism (t(567)
=2.65, p > 0.002, d=0.43), SDQ conduct problems (t(1434)=2.51, p >
0.002, d=0.24) and SDQ emotional problems (t(1434)=1.92, p > 0.002,
d=0.28) were higher than the comparison group. For life satisfaction
the ‘high-risk’ group's mean score was lower than that of the
comparison group (t(1435)=2.64, p > 0.002, d=0.26) (Table 4).
The DSM-5 diagnostic criteria for hypomania requires symptom
duration of at least 4 days. Therefore among the ‘high-risk’ group
(reporting 8 or more hypomanic symptoms which were associated with
negative consequences), those with briefer ‘high’ phases (2–3 days)
were compared to those with ‘highs’ that lasted longer (4 or more days)
on the psychopathological and psychological dimensions. No signiﬁ-
cant diﬀerences were observed between these groups (supplementary
Table 1).
4. Discussion
This study investigated the structure and characterization of
hypomania in a large British adolescent sample. This study's four
speciﬁc objectives will be explored in turn in the following sections.
4.1. Psychometric properties of the HCL
The ﬁrst objective of this study was to explore the structure of
hypomania in a nonclinical sample of British adolescents. The ﬁndings
of this study showed that the HCL items map onto two components:
active-elated and irritable/risk-taking, also referred to as the ‘bright’
and ‘dark’ sides of hypomania respectively. These results are compar-
able to previous studies using clinical (Forty et al., 2010), adult (Meyer
et al., 2007) and non-British (Holtmann et al., 2009) populations
relying on the HCL. In our study, the risk-taking item loaded onto the
active-elated rather than the irritability/risk-taking factor. Results from
previous studies are mixed with regard to this item, with some showing
it loads on to the irritable/risk-taking subscale while others ﬁnd it
maps onto the active-elated dimension (Brand et al., 2011; Forty et al.,
2010).
Higher mean scores on the overall HCL-16 and the active-elated but
not the irritable/risk-taking subscales were observed among those with
a family history of BD compared to those without such a history. These
results concur with the research which shows that family history of BD
is a signiﬁcant risk factor for this disorder and the experience of
hypomanic symptoms (Smoller and Finn, 2003; Youngstrom et al.,
2009). Overall the results concerning the structure of the HCL-16
suggest it maybe a valid hypomanic instrument for youth in the
community.
4.2. Associations between hypomania, psychological and
psychopathological dimensions
The current study's second objective was to assess the construct
validity of the HCL-16 by examining the degree to which HCL-16
scores were correlated with psychopathological (e.g. paranoia) and
psychological (e.g. personality) dimensions known to be associated
with clinical levels of hypomania and BD. The ﬁndings from this study
showed that hypomanic symptoms were signiﬁcantly positively corre-
lated with the majority of the psychopathological dimensions tested
with a few exceptions. The associations between hypomania and
psychotic-like experiences have not been explored in previous studies
using community adolescent samples but results from the current
investigation could be viewed as mirroring the signiﬁcant proportion of
people with BD who also experience psychotic features (Dunayevich
and Keck, 2000). These ﬁndings may highlight a particularly vulnerable
group given that the presentation of hypomanic and psychotic symp-
toms at a clinical level would result in diagnosis of a manic rather than
hypomanic episode (APA, 2013).
The correlations between hypomania, internalizing and externaliz-
ing problems found in this investigation parallels results of previous
studies which have shown high rates of anxiety disorders and ADHD
among people with BD (Merikangas et al., 2011). The results of the
current study indicate that the psychopathological dimensions that are
associated with BD are also linked to hypomanic symptoms in youth,
which oﬀers indirect evidence that the HCL-16 has good construct
validity.
The relationship between the ﬁve main personality dimensions and
hypomanic symptoms has not been investigated in previous studies
using British nonclinical adolescent populations. The novel results in
the current study showed that hypomania was signiﬁcantly associated
with extraversion and openness to experience which is found in other
studies using adult and clinical populations (Tackett et al., 2008). Some
studies also report that BD is positively associated with neuroticism
(Tackett et al., 2008), whereas others show a negative correlation with
agreeableness (Barnett et al., 2011). These results further support the
validity of using the HCL-16 for assessing hypomanic symptoms
among adolescents, and that such symptoms may be linked to
extraversion and openness to experience at this developmental stage.
Sleep disturbance is one of the hallmarks of BD (Harvey, 2008),
although the investigation of this relationship has been ignored in
many studies using community youth samples. The results of this study
showed a signiﬁcant relationship between sleep problems and hypo-
manic symptoms in a community sample of adolescents. The sleep
disturbance measure used in this study covered a range of problems,
including those characteristic of hypomania or mania (e.g. reduced
need for sleep) and depression (eg. diﬃculties falling and staying
asleep) (APA, 2013). These results provide further support of the
validity of the HCL-16 in measuring hypomanic symptoms and show
that the relationship between sleep problems and hypomania may
already be evident in adolescence.
4.3. Comparison between the ‘bright’ and ‘dark’ sides of hypomania
on psychological and psychopathological dimensions
This study's third objective was to compare the two hypomania
dimensions on psychological and psychopathological correlates. The
ﬁndings of this study showed that the ‘dark’ side of hypomania showed
stronger links with externalizing (e.g. conduct problems) and inter-
nalizing (e.g. depression) problems, as well as psychotic-like experi-
ences (e.g. paranoia) relative to the ‘bright’ side. These ﬁndings are
consistent with a previous study of university students which reported
that the ‘dark’ side of hypomania was characterized by symptoms of
depression and more perceived stress compared to the ‘bright’ side
(Brand et al., 2011).
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4.4. Identiﬁcation of group at ‘high-risk’ for BD
The ﬁnal objective of this investigation was to explore whether the
HCL-16 could be used to identify a group of adolescents that show
signs of vulnerability for BD. Currently, identiﬁcation of young people
(particularly in community samples) at risk of developing BD involves
screening for the presence of hypomanic symptoms (Waugh et al.,
2014). Another screening method focuses on other elements of the
diagnostic criteria: impact on functioning and symptom duration
(Holtmann et al., 2009). When both these approaches are combined
a total of 9% of the current sample were identiﬁed as being at ‘high-
risk’ for hypomania and therefore BD to the extent that they reported
the presence of 8 or more hypomanic symptoms (HCL-16 cut-oﬀ for
hypomania) during ‘highs’ that lasted at least 2 days, which were
associated with negative consequences. As expected, the ‘high-risk’
group experienced more psychopathological symptoms relative to the
non-hypomanic group, particularly depression, anxiety sensitivity and
psychotic-like experiences. These associations provide support that this
approach for identifying a ‘high-risk’ group maybe valid, but further
research is needed using a longitudinal study to conﬁrm the outcome of
the individuals in this sample. In the present study the assessment of
sensitivity and speciﬁcity of the HCL-16 was not possible since the
participants did not receive a clinical assessment for BD.
There is some debate surrounding the possible shorter episode
duration in BD (Angst et al., 2003), thus ‘high’ phases of 2 days or more
was the focus in this study. But the DSM-5 diagnostic criteria for
hypomania requires symptom duration of at least 4 days. In comparing
the proﬁle of those in the high-risk group with shorter (2–3 days) to
those with longer phase durations (4 days or more) no signiﬁcant
diﬀerences were observed in the current study. The lack of signiﬁcant
diﬀerences between shorter and longer high phases concurs with the
ﬁndings of previous studies (Hafeman et al., 2013; Stringaris et al.,
2010), which support studying briefer periods of hypomania, especially
among youth, to identify those at risk for BD and/or in need of clinical
attention.
4.5. Clinical implications
Our conclusions are tempered by the fact that our study was cross-
sectional, with no follow-up of individuals. Nevertheless, research such
as ours, on the characterization of adolescent hypomania, will feed into
the development of more eﬀective targeting of prevention and inter-
vention eﬀorts. The ﬁndings of this study are clinically valuable since
they suggest that using the HCL-16 may help practitioners identify
young people vulnerable to developing BD. Second, greater under-
standing of the hypomanic dimensions and their correlates may
provide some explanations surrounding delayed diagnosis of BD. The
results from this study show that the active-elated subscale is asso-
ciated with less psychopathology relative to the irritable/risk-taking
dimension. These ﬁndings suggest that the active-elated dimension
may be linked to fewer problematic issues (eg. better life satisfaction)
which means that individuals scoring highly on this dimension are less
likely to seek help relative to those with higher scores on the irritable/
risk-taking subscale. For this reason it is important that practitioners
are aware of the characterization of the active-elated dimension, as
reported in this study, to help them determine ‘high-risk’ individuals
who are experiencing limited negative consequences and therefore
harder to identify.
4.6. Methodological strengths and limitations
There are several strengths to the current investigation including
the use of a representative community sample of adolescents, which
provides the opportunity to investigate the characterization of hypo-
mania likely to be prior to full-blown illness onset and treatment.
Similar studies employing clinical samples are limited by a number of
possible confounders related to the consequences of the illness. But
several weaknesses need to be considered when interpreting the
ﬁndings from the current investigation.
It was a limitation that the study did not have caregiver or parent
reports available in addition to self-report. Research shows that
caregiver or parent report concerning BD shows the greatest validity
relative to youth and teacher report (Youngstrom et al., 2009).
Although the agreement between parent and youth report of BD is
signiﬁcantly higher than usual cross-informant agreement
(Youngstrom et al., 2009). Previous research also shows that the
HCL has good sensitivity and speciﬁcity for identifying BD (Forty
et al., 2010). In the present study the hypersexuality/ﬂirtatious item
from the HCL-16 was removed for concerns of oﬀending this long-
itudinal sample, which is unfortunate given that this symptom can help
distinguish pediatric BD from other conditions, such as ADHD
(Adelson et al., 2013). Future studies replicating the ﬁndings here
should aim to use the full version of the HCL-16.
Although the sample size was large and consisted of adolescents
from across the UK the participants were one half of a twin pair and
mainly Caucasian, which may limit the generalizability of this study's
ﬁndings. Research supports the assumption that self-reported psychia-
tric symptoms by twins are comparable to singletons (Kendler et al.,
1995). Future studies should use ethnically diverse singleton samples
to conﬁrm the patterns observed in the current study are relevant to
other groups. The exploration of the genetic and environmental
architecture of hypomania in this UK adolescent sample was outside
the scope of the current study but should be the focus of future
investigations, especially since the majority of the existing literature
focuses on adult and/or clinical samples (McGuﬃn et al., 2003).
Substance use may have aﬀected the HCL-16 scores given their
signiﬁcant association in the present study. There are several issues to
consider when interpreting the associations between hypomanic
symptoms and the other dimensions. For instance, given the large
sample size, the correlation coeﬃcients should be the focus here rather
than the signiﬁcance level. Also there was some variation in the index
periods. For example, participants reported on their experience of
hypomanic symptoms during self-identiﬁed ‘high’ periods whereas they
rated other measures using speciﬁc index periods (eg. within the last
month for cognitive disorganization).
The internal consistency of the HCL-16 and its subscales in the
present sample reached acceptable levels, except for the irritable/risk-
taking scale. The levels of endorsement for the items from the irritable/
risk-taking subscale were low (Table 2) and there were fewer items
forming this subscale in comparison to other studies that reported
higher levels of internal consistency (Forty et al., 2010). It should be
noted that previous studies using the HCL-16 have relied on adult
clinical samples (Forty et al., 2010) rather than a community adoles-
cent cohort used here, which may explain such discrepancies. Clearly
the ﬁndings of the present investigation warrant replication to address
these issues.
To summarise, this is one of the few studies to examine the proﬁle
of hypomania in a large British adolescent community sample. The
results showed that hypomania was signiﬁcantly related to various
dimensions of psychopathology, sleep problems and several personality
constructs which mirror relationships observed in adult bipolar
samples. These ﬁndings support the validity of the HCL-16 and, with
further research, may represent a possible tool to identify adolescents
at risk of developing BD.
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